| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/27/2009 | EP1548032B1 Kdr peptides and vaccines comprising the same |
| 05/27/2009 | EP1525219B1 Glp-1 and methods for treating diabetes |
| 05/27/2009 | EP1519915B1 Tricyclic steroid hormone nuclear receptor modulators |
| 05/27/2009 | EP1351672B1 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 05/27/2009 | EP1292678B1 G-protein coupled receptors |
| 05/27/2009 | EP1171424B1 Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors |
| 05/27/2009 | CN101443328A Cocrystal of C-glycoside derivative and L-proline |
| 05/27/2009 | CN101443324A Benzylamine derivatives as CETP inhibitors |
| 05/27/2009 | CN101443311A 1H-indol-5-yl-piperazin-1-yl-methanone derivatives |
| 05/27/2009 | CN101443024A Plant extract and preparation method and use thereof |
| 05/27/2009 | CN101443000A Xanthone derivative for the treatment of muscular disorders |
| 05/27/2009 | CN101442982A Stomach floater composition containing optimization treated starch for inducing satiation sense |
| 05/27/2009 | CN101440369A Expression method of deleted zonula occludens toxin gene of Vibrio cholerae and use |
| 05/27/2009 | CN101440032A Gemfibrozil polycrystalline type and preparation thereof |
| 05/27/2009 | CN101439148A Novel Chinese medicine prescription for treating diabetics |
| 05/27/2009 | CN101439143A Chinese medicine granules containing Anemarrhena asphodefoides extract and preparation method thereof |
| 05/27/2009 | CN101439116A Use of Chinese medicinal composition in preparing medicament for treating diabetes mellitus induced erectile dysfunction |
| 05/27/2009 | CN101439103A Technique for extracting mixed rhubarb and aconite |
| 05/27/2009 | CN101439075A Medicament for increasing high density lipoprotein, preventing and treating atherosclerosis, and preparation method thereof |
| 05/27/2009 | CN101439064A Nourishing tonic for sport |
| 05/27/2009 | CN101439059A Ginkgo leaf extract drop and preparation method thereof |
| 05/27/2009 | CN101439058A Compound Chinese medicine gingko granule and preparation method thereof |
| 05/27/2009 | CN101439057A Chinese medicine granule containing gingko extract and preparation method thereof |
| 05/27/2009 | CN101439049A Method for preparing biochemistry calcium, magnesium and zinc |
| 05/27/2009 | CN101439036A Pharmaceutical composition containing 18 kinds of amino acid |
| 05/27/2009 | CN101439031A Pharmaceutical composition containing 18 kinds of amino acid |
| 05/27/2009 | CN101439027A Effervescent tablet containing L-carnitine-L-tartrate |
| 05/27/2009 | CN101439025A Silymarin high-efficient long-acting preparation and production method thereof |
| 05/27/2009 | CN101439023A Diabetes-treating medicament Gliclazide tablet convenient for dividing dose and method for producing the same |
| 05/27/2009 | CN101438842A Composite beverage |
| 05/27/2009 | CN101438743A Health tea with fat-reducing function |
| 05/27/2009 | CN100491396C Selective cyclic peptides |
| 05/27/2009 | CN100491378C Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharamaceutical compositions comprising them and their use as a medicine |
| 05/27/2009 | CN100491374C 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as C-KIT inhibitors |
| 05/27/2009 | CN100491371C Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (GSK3 inhibitors) |
| 05/27/2009 | CN100491353C Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor |
| 05/27/2009 | CN100490830C Composition with anti-oxidation and metabolism-promotion functions |
| 05/27/2009 | CN100490827C Sugar reducing substance extracted from soybean slag |
| 05/27/2009 | CN100490814C Voglibose dispersion tablet |
| 05/27/2009 | CN100490808C Gliquilone slow-releasing preparation |
| 05/27/2009 | CN100490796C Methodc for preparing sub-micron gemfibrozil medicament powder |
| 05/27/2009 | CN100490791C Compositions and methods to treat neovascularization and disease associated with thereof |
| 05/26/2009 | US7538215 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/26/2009 | US7538135 Benzenesulfonylamino compounds and pharmaceutical compositions containing these compounds |
| 05/26/2009 | US7538125 Pioglitazone insulin sensitivity enhancer with the antidiabetic glimepiride; difference in mechanism of action avoids adverse reactions over long term use; oral dosage tablet; lactose excipient, hydroxypropylcellulose binder, magnesium stearate lubricant, calcium carbonate disintegrator; diabetes |
| 05/26/2009 | US7538124 N-(p-(2-alpha-carboxybenzylamino)ethylamino)phenyl)p-(p-trifluoromethylphenyl)benzamide; hyperlipidemia; antiobesity and anti-type II diabetic agents; Microsomal triglyceride transfer protein inhibitors |
| 05/26/2009 | US7538118 6-aminomorphinane derivatives, method for production and use thereof |
| 05/26/2009 | US7538091 D-retro-inverso amino acid sequence transporter peptide conjugated to nucleic acid biological effector; translocation across the membrane of pancreatic B-cells |
| 05/26/2009 | US7537908 Using concentration of high mobility group 1 (HMG1) protein as evaluative tool in detection of infection and acute respiratory distress syndrome; treating obesity with high mobility group antagonist |
| 05/26/2009 | US7537887 Relates to regulation of activity of NET (ERP/SAP-2) protein and to compounds which modify or regulate NET protein activity; methods of screening for agonists or antagonists of NET in order to identify new pro- or anti-angiogenic compounds |
| 05/26/2009 | US7537756 Using nestin-positive pancreatic stem cell to generate insulin producing beta cells; tissue engineering and repair; regenerative medicine |
| 05/26/2009 | CA2497857C Novel p-selectin ligand protein |
| 05/26/2009 | CA2463264C 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists |
| 05/26/2009 | CA2436668C Novel succinate salt of o-desmethyl-venlafaxine |
| 05/26/2009 | CA2393821C Substituted imidazole neuropeptide y y5 receptor antagonists |
| 05/26/2009 | CA2384504C Use of retigabin for treating neuropathic pain |
| 05/26/2009 | CA2334773C Benzothiepine-1,1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use |
| 05/26/2009 | CA2298523C Therapeutic process for inhibiting nf-.kappa.b |
| 05/26/2009 | CA2254420C Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them |
| 05/26/2009 | CA2230492C Human growth hormone variants |
| 05/26/2009 | CA2091102C Microsomal triglyceride transfer protein |
| 05/22/2009 | WO2009065131A1 Carboxamide, sulfonamide and amine compounds for metabolic disorders |
| 05/22/2009 | WO2009064298A1 Methods for treating obesity and obesity related diseases and disorders |
| 05/22/2009 | WO2009064082A1 Composition comprising galla rhois extract for prevention and treatment of obesity by means of autophagic mechanism |
| 05/22/2009 | WO2009064004A1 Citrulline-containing drink |
| 05/22/2009 | WO2009063993A1 Fused pyridine derivative and use thereof |
| 05/22/2009 | WO2009063992A1 Condensed pyridine derivative and use thereof |
| 05/22/2009 | WO2009063991A1 Pyridooxazepine derivative and use thereof |
| 05/22/2009 | WO2009063987A1 Novel use of processed ginseng |
| 05/22/2009 | WO2009063953A1 Phenylpyrazole derivatives |
| 05/22/2009 | WO2009063821A1 Heteroaryloxy quinazoline derivative |
| 05/22/2009 | WO2009063476A1 A crystalline form of atorvastatin hemi magnesium salt and a process thereof |
| 05/22/2009 | WO2009063061A2 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| 05/22/2009 | WO2009062910A1 Composition for moderating triglyceride and cholesterol levels |
| 05/22/2009 | WO2009062874A2 Benzimidazole derivatives and their use as fxr agonists |
| 05/22/2009 | WO2009062619A1 New crystalline diphenyl acetidinone hydrate, pharmaceutical agent containing said compound and use thereof |
| 05/22/2009 | WO2009062371A1 Carbamate derivatives, and the use as medicament |
| 05/22/2009 | WO2009048945A8 Rapid mucosal gel or film insulin compositions |
| 05/22/2009 | WO2009043507A3 Use of a peptide as a therapeutic agent |
| 05/22/2009 | WO2009043468A3 Use of corticotropin-releasing factor as a therapeutic agent |
| 05/22/2009 | WO2009040087A3 Therapeutic use of peptide yglf and combination with kvlpvpq |
| 05/22/2009 | WO2009040073A3 Use of a peptide as a therapeutic agent |
| 05/22/2009 | WO2009040032A3 Use of a peptide as a therapeutic agent |
| 05/22/2009 | WO2009040025A3 Use of neuropeptide sf, alone or in combination with glp-2, as a therapeutic agent |
| 05/22/2009 | WO2009039969A3 Use of a vla-4 inhibitor tetrapeptide, alone or in combination with bpp-b, as a therapeutic agent |
| 05/22/2009 | WO2009037542A3 Spirocyclic compounds as stearoyl coa desaturase inhibitors |
| 05/22/2009 | WO2009033822A3 Use of a combination of a cathepsin g fragment and teprotide as a therapeutic agent |
| 05/22/2009 | WO2009033812A3 Use of a combination of neuropeptide-ff and alpha-msh as a therapeutic agent |
| 05/22/2009 | WO2009033800A3 Use of a peptide as a therapeutic agent |
| 05/22/2009 | WO2009033771A3 Use of a peptide as a therapeutic agent |
| 05/22/2009 | WO2009033736A3 Use of met-enkephalin as a therapeutic agent |
| 05/22/2009 | WO2009033735A3 Use of melanin concentrating hormone and met-enkephalin as therapeutic agents |
| 05/22/2009 | WO2009033669A3 Use of the peptide his-ser-leu-gly-lys-trp-leu-gly-his-pro-asp-lys-phe alone or in combination with the peptide pro-gly-thr-cys-glu-ile-cys-ala-tyr-ala-ala-cys-thr-gly-cys-oh as a therapeutic agent |
| 05/22/2009 | WO2009031690A3 Foodstuff comprising an extract of a plant of the genus salacia and flavonoid |
| 05/22/2009 | WO2009027956A3 Syndrome x composition and method of lowering blood pressure and glycemic index |
| 05/22/2009 | WO2008145375A3 Kit of nutritional compositions for infants with fat and carbohydrate content adapted to the particular stage of development |
| 05/22/2009 | WO2008092591A9 Use of guanidinoacetic acid (salts) combined with betaine and/or choline for producing a health-promoting agent |
| 05/22/2009 | WO2008040548A3 Treatment for non-alcoholic-steatohepatitis |
| 05/22/2009 | WO2008034032A3 Beta-lactam cannabinoid receptor modulators |
| 05/22/2009 | CA2706556A1 Citrulline-containing beverage |